A new study shows that long-read sequencing has the potential to improve the rate of diagnosis while reducing the time to diagnosis from years to days -- in a single test and at a much lower cost.
A scientific team looks at the progress and challenges in the research and development of brain implants. New achievements in the field of this technology are seen as a source of hope for many ...
The U.S. Food and Drug Administration has pulled draft guidance from its website requiring companies to test medicines and ...
17h
In a viewpoint paper recently published in the journal The Lancet Digital Health, a team led by Stanisa Raspopovic from ...
A new report dives into the evolving clinical trial landscape and transformative therapies changing lives for bladder cancer ...
Xenon gas, currently used in medicine as an anesthetic and neuroprotective agent for treating brain injuries, showed ...
The phage therapy market is experiencing significant growth due to the increasing prevalence of antibiotic-resistant infections and the growing interest in alternative treatments. Advances in ...
One of the earliest proponents of evidence-based medicine, Professor David Sackett, wrote, “Good doctors use both individual ...
Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disease that remains incurable, despite decades of basic and clinical research. Key stakeholders—including the US National ...
DelveInsight's 'Tuberculosis Pipeline Insight 2025' report provides comprehensive global coverage of pipeline tuberculosis ...
Advancements in precision medicine drive the 5-HT2 agonist market by enabling selective targeting of specific receptor subtypes (e.g., 5-HT2A or 5-HT2C), reducing side effects and improving safety.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback